Table 2.
ORF | Gene name |
Fold change (log2)1 |
Description2 | Total abundance3 (log2) |
P- value4 |
---|---|---|---|---|---|
orf19.3537 | 5.47 | Putative sulfiredoxin; biofilm-induced gene; regulated by Tsa1p, Tsa1Bp in minimal medium at 37°C | −3.310 | <0.001 | |
orf19.7469 | ARG1 | 4.73 | Argininosuccinate synthase; arginine biosynthesis; regulated by Gcn4p, Rim101p; induced by amino acid starvation (3-AT) and benomyl treatment; stationary phase enriched protein; repressed in alkalinizing medium; planktonic growth-induced |
−2.256 | 0.002 |
orf19.3107 | 3.65 | Ortholog of Candida dubliniensis CD36 : CD36_46490, Pichia stipitis Pignal : PICST_33598, Candida tropicalis MYA-3404 : CTRG_03758 and Candida albicans WO-1 : CAWG_03126 |
−3.325 | <0.001 | |
orf19.4630 | CPA1 | 3.36 | Putative carbamoyl-phosphate synthase subunit; alkaline down-regulated; transcription is up-regulated in both intermediate and mature biofilms |
−2.646 | 0.022 |
orf19.2285 | 3.22 | Increased transcription is observed upon benomyl treatment | −3.729 | <0.001 | |
orf19.3221 | CPA2 | 3.17 | Putative arginine-specific carbamoylphosphate synthetase; protein enriched in stationary phase yeast cultures; transcription is up-regulated in both intermediate and mature biofilms |
−1.987 | 0.017 |
orf19.4789 | 3.13 | Has domain(s) with predicted metal ion binding activity | −3.971 | 0.048 | |
orf19.2165 | 3.08 | Predicted ORF in Assemblies 19, 20 and 21; induced by nitric oxide | −2.750 | <0.001 | |
orf19.5610 | ARG3 | 3.07 | Putative ornithine carbamoyltransferase; Gcn4p-regulated; Hap43p-induced gene; repressed in alkalinizing medium |
−3.019 | 0.003 |
orf19.6689 | ARG4 | 3.03 | Argininosuccinate lyase, catalyzes the final step in the arginine biosynthesis pathway; alkaline down- regulated; late-stage biofilm-induced |
−2.027 | 0.042 |
orf19.2593 | BIO2 | 2.95 | Putative biotin synthase; transcriptionally up-regulated in high iron; transcription down-regulated by treatment with ciclopiroxolamine; up-regulated in clinical isolates from HIV+ patients with oral candidiasis; Hap43p-repressed |
−3.257 | <0.001 |
orf19.176 | OPT4 | 2.76 | Oligopeptide transporter; detected at germ tube plasma membrane; transcriptionally induced upon phagocytosis by macrophage; fungal-specific (no human or murine homolog); Hap43p-repressed; merged with orf19.2292 in Assembly 20 |
−3.061 | <0.001 |
orf19.3770 | ARG8 | 2.73 | Putative acetylornithine aminotransferase; Gcn2p-, Gcn4p-regulated; transcription is up-regulated in both intermediate and mature biofilms |
−2.480 | 0.028 |
orf19.6229 | CAT1 | 2.71 | Catalase; resistance to oxidative stress, neutrophils, peroxide; role in virulence; regulated by iron, ciclopirox, fluconazole, carbon source, pH, Rim101p, Ssn6p, Hog1p, Hap43p, Sfu1p, Sef1p, farnesol, core stress response |
−1.845 | 0.010 |
orf19.6899 | 2.65 | Putative oxidoreductase; mutation confers hypersensitivity to toxic ergosterol analog | −3.382 | 0.017 | |
orf19.4788 | ARG5,6 | 2.61 | Arginine biosynthetic enzyme activities; in S. cerevisiae, processed into distinct polypeptides with acetylglutamate kinase (Arg6p) activity and acetylglutamate-phosphate reductase (Arg5p) activity; Gcn4p regulated; alkaline down-regulated |
−2.088 | 0.003 |
orf19.3902 | 2.40 | Predicted ORF in Assemblies 19, 20 and 21; decreased transcription is observed upon fluphenazine treatment or in an azole-resistant strain that over-expresses CDR1 and CDR2 |
−3.078 | 0.036 | |
orf19.3395 | 2.36 | Predicted membrane transporter, member of the drug:proton antiporter (12 spanner) (DHA1) family, major facilitator superfamily; induced by nitric oxide, oxidative stress, α-pheromone; fungal-specific; Hap43p-repressed |
−3.151 | 0.001 | |
orf19.5094 | BUL1 | 2.31 | Protein not essential for viability; macrophage/pseudohyphal-induced; similar to S. cerevisiae Bul1p, which may be involved in selection of substrates for ubiquitination |
−2.361 | 0.001 |
orf19.4335 | TNA1 | 2.29 | Putative nicotinic acid transporter; fungal-specific (no human or murine homolog); detected at germ tube plasma membrane by mass spectrometry; transcriptionally induced upon phagocytosis by macrophage |
−3.902 | 0.042 |
orf19.7042 | 2.25 | Increased transcription is observed upon benomyl treatment or in an azole-resistant strain that over- expresses MDR1; induced by nitric oxide |
−2.697 | 0.036 | |
orf19.4773 | AOX2 | 2.22 | Alternative oxidase; induced by antimycin A, some oxidants; growth- and carbon-source-regulated; one of two isoforms (Aox1p and Aox2p); involved in cyanide-resistant respiratory pathway that is absent from S. cerevisiae; Hap43p-repressed |
−2.949 | 0.014 |
orf19.4290 | TRR1 | 2.19 | Thioredoxin reductase; regulated by Tsa1p/Tsa1Bp, Hap43p; induced by nitric oxide, peroxide; oxidative stress-induced via Cap1p; up-regulated by human neutrophils; fungal-specific (no human/murine homolog); stationary phase enriched protein |
−1.407 | <0.001 |
orf19.125 | EBP1 | 2.15 | NADPH oxidoreductase; interacts with phenolic substrates such as 17β-estradiol; possible role in estrogen response; induced by oxidative, weak acid stress, nitric oxide, benomyl, GlcNAc; activated by Cap1p, Mnl1p; Sko1p; Hap43p-repressed |
−2.803 | 0.021 |
orf19.6500 | ECM42 | 2.10 | Putative ornithine acetyltransferase; fungal-specific (no human or murine homolog); Gcn2p-, Gcn4p- regulated; clade-specific gene expression; possibly an essential gene, disruptants not obtained by UAU1 method |
−2.809 | 0.009 |
orf19.113 | CIP1 | 2.07 | Possible oxidoreductase; transcription induced by cadmium but not by other heavy metals, heat shock, yeast-hyphal switch, oxidative stress (via Cap1p), or macrophage interaction; stationary phase enriched protein |
−3.055 | 0.019 |
orf19.4689 | PGA57 | 2.05 | Putative GPI-anchored protein; Hap43p-induced gene | −3.348 | <0.001 |
orf19.3131 | OYE32 | 2.04 | NAD(P)H oxidoreductase family protein; induced by nitric oxide, amphotericin B, oxidative stress (via Cap1p); increased transcription associated with MDR1 over-expression or benomyl treatment; macrophage-down-regulated protein abundance |
−2.821 | 0.0003 |
orf19.5741 | ALS1 | 2.01 | Adhesin; ALS family of cell-surface glycoproteins; adhesion, virulence roles; immunoprotective; band at hyphal base; amyloid domain; biofilm-induced; Rfg1p, Ssk1p; strain background affects expression; N- term binds fucose-containing glycans |
−0.998 | <0.001 |
orf19.3981 | MAL31 | 1.98 | Putative high-affinity maltose transporter; transcription is up-regulated in clinical isolates from HIV+ patients with oral candidiasis; alkaline up-regulated |
−2.581 | 0.005 |
orf19.5908 | TEC1 | 1.97 | TEA/ATTS transcription factor; involved in white cell pheromone response, regulates hypha-specific genes, biofilm formation; regulates BCR1; transcription regulated by Cph2 in some conditions; alkaline- and biofilm-induced |
−2.348 | 0.050 |
orf19.2970 | LYS2 | 1.96 | Large subunit of heterodimeric α-aminoadipate reductase; enzyme of lysine biosynthesis; contains predicted binding sites for AMP and α-aminoadipate; feedback inhibited by lysine or thialysine; regulated by Gcn2p and Gcn4p |
−1.794 | 0.030 |
orf19.4873 | 1.89 | Biofilm-induced gene; expression is regulated upon white-opaque switching | −3.192 | 0.009 | |
orf19.2724 | 1.88 | Hap43p-repressed gene; late-stage biofilm induced | −2.217 | 0.007 | |
orf19.4274 | PUT1 | 1.83 | Putative proline oxidase; alkaline up-regulated by Rim101p; biofilm-induced | −2.623 | 0.011 |
orf19.3803 | MNN22 | 1.57 | Putative Golgi α-1,2-mannosyltransferase; regulated by Tsa1p, Tsa1Bp in minimal media at 37°C; Hog1p-induced; induced by nitric oxide; down-regulated in core stress response; planktonic growth- induced gene |
−2.198 | 0.002 |
orf19.2833 | PGA34 | 1.55 | Putative GPI-anchored protein; transcription is repressed in response to α-pheromone in Spider M medium; late-stage biofilm-induced gene; induced in oropharyngeal candidiasis |
−3.811 | 0.035 |
CaalfMr16 | RRNL | 1.55 | Mitochondrial ribosomal RNA of the large ribosomal subunit | 0.022 | 0.002 |
orf19.4513 | 1.53 | Protein not essential for viability | −2.036 | 0.013 | |
orf19.701 | CFL11 | 1.51 | Protein similar to ferric reductase Fre10p; flucytosine repressed; possibly adherence-induced; possibly an essential gene, disruptants not obtained by UAU1 method |
−3.182 | 0.008 |
orf19.2262 | 1.50 | Protein similar to quinone oxidoreductases; increased transcription upon benomyl treatment; induced by nitric oxide; oxidative stress-induced via Cap1p; stationary-phase enriched protein |
−2.494 | 0.002 | |
orf19.276 | 1.48 | Plasma membrane-associated protein; increased transcription is observed in an azole-resistant strain that over-expresses MDR1; Hap43p-repressed gene |
−2.959 | 0.035 | |
orf19.7637 | YHB4 | 1.46 | Protein related to flavohemoglobins; not required for wild-type nitric oxide resistance; has predicted globin, FAD-binding, and NAD(P)-binding domains but lacks some conserved residues of flavohemoglobins; Hap43p-repressed gene |
−2.416 | 0.007 |
orf19.1651 | 1.44 | Ortholog of Candida dubliniensis CD36 : CD36_81960, Candida tropicalis MYA-3404 : CTRG_02378 and Candida albicans WO-1 : CAWG_02525 |
−3.581 | 0.045 | |
orf19.2020 | HGT6 | 1.43 | Putative high-affinity major facilitator superfamily glucose transporter; 20 family members; 12 probable membrane-spanning segments; core stress response, fluconazole-induced; biofilm-induced; induced in oropharyngeal candidiasis |
−1.355 | 0.033 |
orf19.7417 | TSA1 | 1.43 | TSA/alkyl hydroperoxide peroxidase C (AhPC) family protein; similar to thiol-dependent peroxidases of oxidative stress signaling; antigenic; hyphal surface, nucleus; yeast-form nucleus, cytoplasm; biofilm, phagocytosis, peroxide induced |
−1.232 | 0.034 |
orf19.7398 | 1.42 | Hap43p-induced gene; decreased expression in response to prostaglandins | −1.227 | 0.031 | |
orf19.4482 | IFI3 | 1.42 | Predicted ORF in Assemblies 19, 20 and 21; constitutive expression independent of MTL or white- opaque status |
−2.289 | 0.003 |
orf19.85 | GPX2 | 1.42 | Similar to glutathione peroxidase; expression greater in high iron; alkaline up-regulated by Rim101p; transcriptionally induced by α-factor or interaction with macrophage; regulated by Efg1p; caspofungin repressed |
−2.053 | 0.006 |
orf19.2809 | CTN3 | 1.41 | Predicted peroxisomal carnitine acetyl transferase; Ura+ deletion strain has no obvious metabolic, hyphal, or virulence defects; transcription induced by macrophage engulfment, hyphal growth, starvation, or non- fermentable carbon sources |
−2.913 | 0.034 |
orf19.7244 | 1.40 | Putative fumarylacetoacetate hydrolase; biofilm-induced gene; induced by nitric oxide independent of Yhb1p; regulated by Sef1p, Sfu1p, and Hap43p |
−2.277 | 0.043 | |
orf19.6501 | 1.40 | Ortholog of Candida dubliniensis CD36 : CD36_71960, Spathaspora passalidarum NRRL Y-27907 : SPAPADRAFT_63786, Candida tropicalis MYA-3404 : CTRG_05049 and Candida albicans WO-1 : CAWG_05564 |
−3.862 | 0.043 | |
orf19.5760 | IHD1 | 1.39 | Putative GPI-anchored protein; alkaline up-regulated; greater transcription in hyphal form than yeast form; regulated by Nrg1p, Rfg1p, Tup1p; regulated by Tsa1p, Tsa1Bp in minimal media at 37°C; induced in oropharyngeal candidiasis |
−1.770 | 0.016 |
orf19.5140 | 1.38 | Ortholog of Candida dubliniensis CD36 : CD36_72790 and Candida albicans WO-1 : CAWG_05648 | −3.507 | 0.017 | |
orf19.1037 | 1.37 | Ortholog of Candida tenuis NRRL Y-1498 : CANTEDRAFT_114303, Candida dubliniensis CD36 : CD36_03460, Pichia stipitis Pignal : PICST_63037 and Spathaspora passalidarum NRRL Y-27907 : SPAPADRAFT_136773 |
−1.996 | 0.004 | |
orf19.84 | CAN3 | 1.36 | Hap43p-repressed gene; expression is regulated upon white-opaque switching | −2.433 | 0.010 |
orf19.4370 | 1.35 | Predicted ORF in Assemblies 19, 20 and 21; induced by nitric oxide; oxidative stress-induced via Cap1p; fungal-specific (no human or murine homolog) |
−2.730 | 0.010 | |
orf19.1363 | 1.34 | Putative protein of unknown function; late-stage biofilm-induced gene; Plc1p-regulated; transcriptionally activated by Mnl1p under weak acid stress |
−2.494 | 0.011 | |
orf19.3142 | 1.34 | Ortholog of C. parapsilosis CDC317 : CPAR2_501210, Candida tenuis NRRL Y-1498 : CANTEDRAFT_97195, Debaryomyces hansenii CBS767 : DEHA2E08800g and Candida dubliniensis CD36 : CD36_46140 |
−3.388 | 0.045 | |
orf19.238 | CCP1 | 1.30 | Similar to cytochrome-c peroxidase N terminus; negatively regulated by Rim101p or alkaline pH; transcription induced by interaction with macrophage or low iron; oxygen-induced activity; regulated by Sef1p, Sfu1p, and Hap43p |
−1.804 | 0.045 |
orf19.3122.2 | 1.29 | Ortholog(s) have role in exocytosis, filamentous growth, mRNA export from nucleus, proteasomal ubiquitin-dependent protein catabolic process, proteasome assembly, regulation of cell cycle |
−2.692 | 0.010 | |
orf19.6994 | BAT22 | 1.26 | Putative branched chain amino acid aminotransferase; regulated by Gcn4p; induced by farnesol treatment, GlcNAc, amino acid starvation (3-aminotriazole treatment); present in exponential and stationary growth phase yeast cultures |
−2.006 | 0.028 |
orf19.5762 | PGA61 | 1.26 | Putative GPI-anchored protein | −3.810 | 0.044 |
orf19.699 | 1.25 | Biofilm-induced gene | −2.757 | 0.035 | |
orf19.690 | PLB2 | 1.25 | Putative phospholipase B; conserved catalytic region; 6 putative N-glycosylation motifs; predicted secretion signal; no GPI anchor predicted; fungal-specific (no human or murine homolog) |
−3.009 | 0.017 |
orf19.3443 | OYE2 | 1.24 | Putative NAPDH dehydrogenase; fungal-specific (no human or murine homolog); induced by nitric oxide | −2.530 | 0.011 |
orf19.4653 | 1.24 | Transcriptionally regulated by iron; expression greater in low iron; similar to GPI-linked cell-wall proteins | −2.937 | 0.034 | |
orf19.3528 | 1.21 | Ortholog(s) have cytosol, nucleus localization | −3.001 | 0.023 | |
orf19.847 | YIM1 | 1.20 | Protein similar to protease of mitochondrial inner membrane; increased transcription is observed upon benomyl treatment; macrophage-down-regulated gene |
−2.193 | 0.019 |
orf19.1077 | ATM1 | 1.15 | Member of MDR subfamily of ABC family; similar to S. cerevisiae ABC transporter, Atm1p; transcriptionally regulated by iron; expression greater in low iron; induced by nitric oxide independent of Yhb1p |
−2.405 | 0.030 |
CaalfMr17 | RRNS | 1.13 | Mitochondrial ribosomal RNA of the small ribosomal subunit | 0.567 | 0.014 |
orf19.1701 | RKI1 | 1.11 | Ortholog(s) have ribose-5-phosphate isomerase activity, role in pentose-phosphate shunt, pyridoxine biosynthetic process and cytoplasm, nucleus localization |
−2.653 | 0.038 |
orf19.6947 | GTT11 | 1.10 | Glutathione S-transferase, localized to ER; induced in exponentially growing cells, under oxidative stress; induced by nitric oxide |
−2.348 | 0.019 |
orf19.4147 | GLR1 | 1.03 | Glutathione reductase; up-regulated by human neutrophils; oxidative stress-induced regulation via Cap1p; over-expression correlates with multidrug resistance in a cap1 mutant, farnesol induced; stationary phase enriched protein |
−1.585 | 0.029 |
orf19.7567 | 1.03 | Predicted ORF in Assemblies 19, 20 and 21; transcription is induced in response to α-pheromone in Spider M medium |
−2.655 | 0.043 | |
orf19.2179.2 | RPS10 | −0.99 | Ribosomal protein S10; down-regulated in the presence of human whole blood or polymorphonuclear (PMN) cells |
−1.674 | 0.041 |
orf19.54 | RHD1 | −1.01 | Putative β-mannosyltransferase, required for the addition of β-mannose to the acid-labile fraction of cell wall phosphopeptidomannan; member of a 9-gene family; transcriptionally regulated on yeast-hyphal and white-opaque switches |
−1.871 | 0.034 |
orf19.1860.1 | −1.03 | Has domain(s) with predicted aminopeptidase activity and role in proteolysis | −1.689 | 0.041 | |
orf19.5839 | PDR17 | −1.08 | Fungal-specific protein (no human or murine homolog); role in sensitivity to fluconazole, specifically | −2.608 | 0.023 |
orf19.1264 | CFL2 | −1.08 | Putative oxidoreductase, iron utilization; regulated by Sfu1p, Sef1p, Hap43p, Nrg1p, Tup1p, Rim101p; alkaline, low iron, fluphenazine, ciclopirox olamine, flucytosine, fluconazole, biofilm induced; caspofungin, amphotericin B repressed |
−1.512 | 0.047 |
orf19.252 | −1.09 | Putative protein of unknown function; Hap43p-repressed gene; S. cerevisiae ortholog FMP37 localizes to mitochondria |
−2.420 | 0.047 | |
orf19.4151 | SPO1 | −1.25 | Protein similar to phospholipase B; fungal-specific (no human or murine homolog) | −3.236 | 0.042 |
orf19.5673 | OPT7 | −1.25 | Putative oligopeptide transporter; possibly transports GSH or related compounds; induced by biofilm formation; Hog1p-induced; expression of OPT6, -7, or -8 does not suppress defect of mutant lacking OPT1-3; fungal-specific; Hap43p-repressed |
−2.516 | 0.049 |
orf19.1258 | −1.30 | Putative adhesin-like protein; regulated by Tsa1p, Tsa1Bp in minimal media at 37°C; transcription is induced in response to alpha pheromone in Spider M medium; clade-associated gene expression; Hap43p-induced gene |
−2.537 | 0.030 | |
orf19.5806 | ALD5 | −1.32 | NAD-aldehyde dehydrogenase; decreased expression in fluconazole-resistant isolate, or in hyphae; biofilm induced; fluconazole-down-regulated; protein abundance is affected by URA3 expression in the CAI-4 strain; stationary phase enriched |
−0.500 | 0.014 |
snR61 | −1.40 | C/D box small nucleolar RNA (snoRNA) | −3.152 | 0.045 | |
orf19.5986 | THI4 | −1.48 | Thiamine biosynthetic enzyme precursor; repressed during the mating process; fungal-specific (no human or murine homolog); stationary phase enriched protein; planktonic growth-induced gene |
−3.220 | 0.046 |
orf19.2619 | PHO113 | −1.48 | Putative constitutive acid phosphatase; transcription is negatively regulated by Rim101p; DTT- extractable; N-glycosylated; possibly an essential gene, disruptants not obtained by UAU1 method |
−2.760 | 0.036 |
orf19.1608 | −1.61 | Ortholog(s) have cytosol, nucleus localization | −2.858 | 0.032 | |
orf19.984 | PHO8 | −1.66 | Putative repressible vacuolar alkaline phosphatase; transcription is positively regulated by Rim101p; regulated by Tsa1p, Tsa1Bp in minimal media at 37°C; possibly adherence-induced |
−3.745 | 0.023 |
orf19.1263 | CFL1 | −1.78 | Protein similar to ferric reductase Fre10p; possible functional homolog of S. cerevisiae Fre1p (reports differ); transcription is negatively regulated by Sfu1p, copper, amphotericin B, caspofungin; induced by ciclopirox olamine |
−1.393 | <0.001 |
orf19.6570 | NUP | −1.82 | Nucleoside permease; adenosine and guanosine are substrates, whereas cytidine, adenine, guanine, uridine, uracil are not; similar to a nucleoside permease of S. pombe; possibly processed by Kex2p |
−2.942 | 0.006 |
orf19.3934 | CAR1 | −1.85 | Arginase involved in arginine catabolism; transcription regulated by Nrg1p, Mig1p, and Tup1p; colony morphology-related regulation by Ssn6p; alkaline up-regulated; protein decreased in stationary phase; biofilm-induced; sumoylation target |
−1.998 | <0.001 |
tE(UUC)4 | tE(UUC)4 | −1.92 | tRNA-Glu, predicted by tRNAscan-SE; UUC anticodon | −3.276 | 0.046 |
orf19.4211 | FET3 | −1.98 | Multicopper oxidase; required for growth in low-iron; required for prostaglandin E2 production; functional homolog of S. cerevisiae Fet3p; ketoconazole, caspofungin, amphotericin B repressed; regulated by Sef1p, Sfu1p, and Hap43p |
−0.909 | <0.001 |
RDN18 | RDN18 | −2.01 | 18S ribosomal RNA; component of the small (40S) ribosomal subunit; encoded in about 55 copies of the rDNA repeat on Chromosome R |
−0.717 | 0.003 |
tI(AAU)2 | tI(AAU)2 | −2.07 | tRNA-Ile, predicted by tRNAscan-SE; AAU anticodon | −3.416 | 0.022 |
snR57b | −2.12 | C/D box small nucleolar RNA (snoRNA) | −3.210 | 0.005 | |
tE(UUC)6 | tE(UUC)6 | −2.12 | tRNA-Glu, predicted by tRNAscan-SE; UUC anticodon | −3.135 | 0.050 |
orf19.3152 | AMO2 | −2.21 | Protein similar to A. niger predicted peroxisomal copper amino oxidase; mutation confers hypersensitivity to toxic ergosterol analog; induced upon biofilm formation |
−1.986 | 0.011 |
orf19.6520 | −2.22 | Putative allantoate permease; fungal-specific (no human or murine homolog) | −3.636 | 0.042 | |
tE(UUC)3 | tE(UUC)3 | −2.24 | tRNA-Glu, predicted by tRNAscan-SE; UUC anticodon | −3.269 | 0.028 |
snR69 | −2.40 | C/D box small nucleolar RNA (snoRNA) | −3.517 | 0.025 | |
orf19.2652 | TEF4 | −2.46 | Putative translation elongation factor; genes encoding ribosomal subunits, translation factors, and tRNA synthetases are down-regulated upon phagocytosis by murine macrophage |
−3.230 | 0.003 |
orf19.7071 | FGR2 | −2.73 | Protein similar to phosphate transporters; transposon mutation affects filamentous growth; expression is regulated upon white-opaque switching |
−3.598 | 0.010 |
snR67 | −2.78 | C/D box small nucleolar RNA (snoRNA) | −3.508 | 0.009 | |
orf19.2197 | −2.95 | Has domain(s) with predicted N,N-dimethylaniline monooxygenase activity, NADP binding, flavin adenine dinucleotide binding activity and role in oxidation-reduction process |
−3.766 | 0.020 | |
orf19.4599 | PHO89 | −3.70 | Putative phosphate permease; expression is regulated upon white-opaque switching; alkaline up- regulated by Rim101p; induced upon biofilm formation; possibly adherence-induced |
−2.523 | 0.001 |
orf19.1344 | −4.12 | Predicted ORF in Assemblies 19, 20 and 21; fluconazole-induced | −2.533 | 0.003 | |
tL(UAA)3 | tL(UAA)3 | −4.66 | tRNA-Leu, predicted by tRNAscan-SE; UAA anticodon | −3.785 | 0.003 |
xi-Rb | Inf | Long terminal repeat (LTR); about 387 bp long, 5 copies per genome | −4.329 | 0.029 |
Positive values, up-regulated; negative values, down-regulated (log2 ≥1.0 equivalent to ≥ twofold linear change)
Description details from the CGD (www.candidagenome.org)
Abundance reads represent the fractional expression of all targets in the genome
P-values were calculated from DESeq and adjusted P-values ≤ 0.050 were considered to be significant